[1] DA COSTA JP, VITORINO R, SILVA GM, et al. A synopsis on aging-Theories, mechanisms and future prospects. Ageing Res Rev. 2016; 29:90-112.
[2] CHEN C, ZHOU M, GE Y, et al. SIRT1 and aging related signaling pathways. Mech Ageing Dev. 2020;187:111215.
[3] WANG Z, LIN Y, JIN S, et al. Bone marrow mesenchymal stem cells improve thymus and spleen function of aging rats through affecting P21/PCNA and suppressing oxidative stress. Aging. 2020;12(12): 11386-11397.
[4] CONTE M, MARTUCCI M, CHIARIELLO A, et al. Mitochondria, immunosenescence and inflammaging: a role for mitokines? Semin Immunopathol. 2020;42(5):607-617.
[5] BORGONI S, KUDRYASHOVA KS, BURKA K, et al. Targeting immune dysfunction in aging. Ageing Res Rev. 2021;70:101410.
[6] THAPA P, FARBER DL. The Role of the Thymus in the Immune Response. Thorac Surg Clin. 2019;29(2):123-131.
[7] MITTELBRUNN M, KROEMER G. Hallmarks of T cell aging. Nat Immunol. 2021;22(6):687-698.
[8] EL-NASEERY NI, MOUSA HSE, NORELDIN AE, et al. Aging-associated immunosenescence via alterations in splenic immune cell populations in rat. Life Sci. 2020;241:117168.
[9] KUMARI R, JAT P. Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype. Front Cell Dev Biol. 2021;9:645593.
[10] 杨丽华.SASP与细胞衰老的研究进展[J].科技风,2021(15):164-165.
[11] 张梦思,邹婷,叶渊文,等.当归多糖对衰老模型大鼠脾脏结构与功能的影响[J].解剖学报,2015,46(2):257-264.
[12] FAHY GM, BROOKE RT, WATSON JP, et al. Reversal of epigenetic aging and immunosenescent trends in humans. Aging cell. 2019;18(6): e13028.
[13] WANG J, LIU S, SHI J, et al. The Role of lncRNAs in Osteogenic Differentiation of Bone Marrow Mesenchymal Stem Cells. Curr Stem Cell Res Ther. 2020;15(3):243-249.
[14] CHARIF N, LI YY, TARGA L, et al. Aging of bone marrow mesenchymal stromal/stem cells: Implications on autologous regenerative medicine. Biomed Mater Eng. 2017;28(s1):S57-S63.
[15] FU X, LIU G, HALIM A, et al. Mesenchymal Stem Cell Migration and Tissue Repair. Cells. 2019;8(8):784.
[16] CHEN Q, SHOU P, ZHENG C, et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ. 2016;23(7): 1128-1139.
[17] HE Y, CHEN D, YANG L, et al. The therapeutic potential of bone marrow mesenchymal stem cells in premature ovarian failure. Stem Cell Res Ther. 2018;9(1):263.
[18] MIAO C, LEI M, HU W, et al. A brief review: the therapeutic potential of bone marrow mesenchymal stem cells in myocardial infarction. Stem Cell Res Ther. 2017;8(1):242.
[19] CHEN D, TANG P, LIU L, et al. Bone marrow-derived mesenchymal stem cells promote cell proliferation of multiple myeloma through inhibiting T cell immune responses via PD-1/PD-L1 pathway. Cell Cycle. 2018; 17(7):858-867.
[20] ZHANG Y, ZHOU S, HU JM, et al. Preliminary Study of Bone Marrow-Derived Mesenchymal Stem Cells Pretreatment With Erythropoietin in Preventing Acute Rejection After Rat Renal Transplantation. Transplant Proc. 2018;50(10):3873-3880.
[21] ZHU Y, GE J, HUANG C, et al. Application of mesenchymal stem cell therapy for aging frailty: from mechanisms to therapeutics. Theranostics. 2021;11(12):5675-5685.
[22] CHU DT, PHUONG TNT, TIEN NLB, et al. An Update on the Progress of Isolation, Culture, Storage, and Clinical Application of Human Bone Marrow Mesenchymal Stem/Stromal Cells. Int J Mol Sci. 2020; 21(3):708.
[23] 王严影,杨育坤,朱向情,等.骨髓间充质干细胞移植干预衰老猕猴胸腺结构和功能的变化[J].中国组织工程研究,2021,25(1):13-19.
[24] PYO IS, YUN S, YOON YE, et al. Mechanisms of Aging and the Preventive Effects of Resveratrol on Age-Related Diseases. Molecules. 2020;25(20):4649.
[25] 徐舜,崔红晶,赵炜,等.细胞衰老分子机制的研究进展[J].广东医科大学学报,2020,38(1):1-10.
[26] ELYAHU Y, MONSONEGO A. Thymus involution sets the clock of the aging T-cell landscape: Implications for declined immunity and tissue repair. Ageing Res Rev. 2021;65:101231.
[27] RHESUS MACAQUE GENOME SEQUENCING AND ANALYSIS CONSORTIUM, GIBBS RA, ROGERS J, et al. Evolutionary and biomedical insights from the rhesus macaque genome. Science. 2007;316(5822):222-234.
[28] CAMPISI J, D’ADDA DI FAGAGNA F. Cellular senescence: when bad things happen to good cells. Nat Rev Mol Cell Biol. 2007;8(9):729-740.
[29] DUTTO I, TILLHON M, CAZZALINI O, et al. Biology of the cell cycle inhibitor p21CDKN1A: molecular mechanisms and relevance in chemical toxicology. Archives of Toxicology. 2014;89(2):155-178.
[30] CAZZALINI O, SCOVASSI AI, SAVIO M, et al. Multiple roles of the cell cycle inhibitor p21(CDKN1A) in the DNA damage response. Mutat Res. 2010;704(1-3):12-20.
[31] SHMULEVICH R, KRIZHANOVSKY V. Cell Senescence, DNA Damage, and Metabolism. Antioxid Redox Signal. 2021;34(4):324-334.
[32] LIU H, LI D, ZHANG Y, et al. Inflammation, mesenchymal stem cells and bone regeneration. Histochem Cell Biol. 2018;149(4):393-404.
|